ASB16 and cancer: The results showed that in the 5 cancer types—adrenocortical carcinoma (ACC, p =0.002; ovarian serous cystadenocarcinoma (OV), p =0.023; PAAD, p =0.012; SKCM, p =0.040 and THCA, p =0.043)—ASB16-AS1 was differentially expressed in the overall stages (Figure 3a).